JAK2 and neoplasm: In our current study, we gathered clinical samples of ATC, PTC, and NT tissues and established a noteworthy confirmation of the heightened expression levels of JAK1, p-JAK1, JAK2, p-JAK2, STAT3, and p-STAT3 proteins within the tumor cells of ATC patients.